🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

No. 2 U.S. House Republican Scalise diagnosed with blood cancer

Published 08/29/2023, 10:56 AM
Updated 08/29/2023, 11:16 AM
© Reuters. FILE PHOTO: U.S. House Majority leader Steve Scalise (R-LA) speaks during a press conference following a Republican conference meeting on Capitol Hill in Washington, U.S., July 12, 2023. REUTERS/Evelyn Hockstein/File photo

WASHINGTON (Reuters) -U.S. House of Representatives Republican leader Steve Scalise said on Tuesday he has been diagnosed with multiple myeloma, a common form of blood cancer.

"I am incredibly grateful we were able to detect this early and that this cancer is treatable," Scalise said in a statement, adding that he would continue working throughout the monthslong treatment.

© Reuters. FILE PHOTO: U.S. House Majority leader Steve Scalise (R-LA) speaks during a press conference following a Republican conference meeting on Capitol Hill in Washington, U.S., July 12, 2023. REUTERS/Evelyn Hockstein/File photo

The congressman from Louisiana, the No. 2-ranking Republican in the House, was injured in a shooting in 2017, when a gunman attacked lawmakers practicing for an annual charity baseball game. Scalise underwent several surgeries to repair internal organs and broken bones following the assault.

U.S. Representative Jamie Raskin, a Democrat, said in December that he had been diagnosed with a form of lymphoma. Raskin announced in April that he was in remission.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.